LEDA Pharma

Bierbeek ·KBO/BCE: BE 0825.107.833

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	31-07-2026	on the day	2026-00381080
31-12-2024	31-07-2025	31-07-2025	on the day	2025-00363057
31-12-2023	31-07-2024	18-07-2024	13 d early	2024-00264165
31-12-2022	31-07-2023	23-06-2023	38 d early	2023-00152216
31-12-2021	31-07-2022	26-07-2022	5 d early	2022-20240061
31-12-2020	31-07-2021	31-08-2021	31 d late	2021-64300468
31-12-2019	31-07-2020	09-06-2020	52 d early	2020-15800183
31-12-2018	31-07-2019	17-06-2019	44 d early	2019-19500350
31-12-2017	31-07-2018	12-06-2018	49 d early	2018-18200145
31-12-2016	31-07-2017	29-06-2017	32 d early	2017-26100310

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€92k
Fixed assets	21/28	€79k
Tangible fixed assets	22/27	€79k
Current assets	29/58	€13k
Amounts receivable within one year	40/41	€13k
Investments	50/53	€351
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€92k
Equity	10/15	€-51k
Contributions / capital	10/11	€6k
Accumulated profits (losses)	14	€-57k
Amounts payable	17/49	€143k
Amounts payable after one year	17	€51k
Amounts payable within one year	42/48	€92k
Trade debts payable within one year	44	€145
Income statement
Gross operating margin	9900	€22k
Operating result	9901	€11k
Financial charges	65	€4k
Result before taxes	9903	€7k
Net result for the period	9904	€7k
Result to be appropriated	9905	€7k

Summary